Keynote & Exhibit Pass offers you access to:
- 10 PLENARY KEYNOTE PRESENTATIONS
- KEYNOTE PANEL DISCUSSION – WOMEN IN SCIENCE
- KEYNOTE PANEL DISCUSSION: IMPLEMENTING PRECISION MEDICINE AT BIG PHARMA
TUESDAY, FEBRUARY 16
10:55 am FDA Update on COVID-19 Molecular Diagnostic Testing
Timothy Stenzel, MD, PhD, Director, Office of In Vitro Diagnostics and Radiological Health, FDA
11:20 RADx Tech: A New Paradigm for MedTech Development
Steven Schachter, MD, Professor, Neurology, Harvard Medical School; Chief Academic Officer and RADx Chief, CIMIT
11:45 From Influenza, to Ebola to Zika: How a Decade of Experience and Investments Prepared Us to Respond to This Pandemic
Robert A. Johnson, PhD, Influenza Director, Biomedical Advanced R&D Authority, US Department of Health & Human Services
12:05 Sponsored Presentation
Speaker to be Announced
12:10 Global Public Health Consortium: A Path for Global Biosecurity through Equity and Transparency
W. Ian Lipkin, MD, Director, Center for Infection and Immunity, Columbia University
WEDNESDAY, FEBRUARY 17
10:30 am Women in Science
Panelists:
Hanneke Schuitemaker, PhD, Vice President, Viral Vaccine Discovery & Translational Medicine, Janssen Vaccines & Prevention B.V.; Professor, Virology, Amsterdam University Medical Center
Carolyn Compton, MD, PhD, FCAP, Professor, Life Sciences, Arizona State University; Professor of Laboratory Medicine and Pathology, Mayo College of Medicine; CMO, National Biomarker Development Alliance
Malileh Poorfarhani, Director, Digital Health and R&D, Bayer
1:20 pm Exploring New Therapies for COVID-19: Focus on AstraZeneca’s Long-Acting Monoclonal Antibody Combination
Mark T. Esser, PhD, Vice President, Microbial Sciences, BioPharma R&D, AstraZeneca
1:45 Janssen’s Efforts in the Development of a COVID-19 Vaccine
Hanneke Schuitemaker, PhD, Vice President, Viral Vaccine Discovery & Translational Medicine, Janssen Vaccines & Prevention B.V.; Professor, Virology, Amsterdam University Medical Center
2:10 Developing a COVID Vaccine in Ten Months
Sanjay Gurunathan, MD, Vice President and Head, Global Clinical Department, Sanofi Pasteur
THURSDAY, FEBRUARY 18
11:40 am Turning Science into Medicine: The Power of Collaboration
Mene N. Pangalos, PhD, Executive Vice President Biopharmaceuticals R&D, AstraZeneca
12:05 Talk Title to be Announced
Hakan Sakul, PhD, Vice President and Head, Diagnostics, Pfizer
12:40 Keynote Panel Discussion: Implementing Precision Medicine at Big Pharma
Moderator:
Cecilia Schott, PharmD, MBA, Head, Global Precision Medicine Strategy, Oncology Business Unit, Novartis
Panelists:
Hakan Sakul, PhD, Vice President and Head, Diagnostics, Pfizer
Maria C. M. Orr, PhD, FRSB, Head of Precision Medicine, Biopharmaceuticals, AstraZeneca
Clinical Trial Assay & CDx Development in the era of Precision Medicine – Planning for Success
Katarina Wikstrom, PhD, Head of US Operations, Almac Group
SARS-CoV-2 Diagnostics by NGS: Interesting Challenges and Scalable Solutions
Jeremy Ellis, PhD, CSO, Fry Laboratories, LLC
Transforming COVID-19 Testing Through BGI/MGI Clinical Lab Partnership Program
Charles Bao, General Manager, BGI Americas
Exosome-Based Digital PCR for FGFR Assessment in Bladder Cancer
Ronny Kellner, Senior Scientist, dPCR Assay Development, dPCR Assay Development, Qiagen
Clinical Development of a Liquid Biopsy Platform to Aid in the Diagnosis and Treatment of Lung Cancer
Robert J. Mattaliano, PhD, COO, Sanmed Diagnostics Inc.
A Single-Stranded NGS Approach to cfDNA Precision Oncology for Improved Fragmentomic Analyses
Varsha Rao, Director, Clinical R&D, Claret Bioscience LLC
Rapid Analytics for Coronavirus Vaccines using the VaxArray Platform
Erica Dawson, PhD, Chief Technical Officer, InDevR
Transforming Surveillance into Analytics for Predictive Biomarkers and Clinical Diagnostics in Oncology
Mark Gramling, PhD, Director of Oncology, Larvol
Development and Commercialization of a Novel High-Throughput CRISPR-Based SARS-CoV-2 Test
Xin Miao, PhD, Director Assay Development, Mammoth Biosciences
Tim Patno, VP, Product Development, Mammoth Biosciences
Profiling Exhausted T Cells using Vectra® Polaris™ Multiplex Immunofluorescence Assay in HNSCC
Sara Pollan, PhD, Scientist, Multiplexing, NeoGenomics Laboratories
NGS Liquid Biopsy Testing for Solid Tumors: Clinical Trials and Routine Diagnostics
James Yen, PhD, Principal Scientist, Associate Scientific Director, Pharma Services, NeoGenomics Laboratories
A Rapid Lateral Flow Test Detecting SARS-CoV-2 Neutralizing Antibodies
Jianfu Wang, PhD, CEO, Innovation, Novodiax Inc.
Advancing Highly Multiplexed Liquid and Tissue Biopsy: Introducing RareCyte’s Orion Platform
Tad George, PhD, Sr. VP of Biology R&D, R&D, RareCyte, Inc.
The SomaScan® Assay: Biomarker Discovery to Delivery
Sheri Wilcox, PhD, Senior Director, Scientific Liaison and Technical Support, SomaLogic, Inc.
New Platform for Liquid Biopsy Enables Precise Cancer Diagnosis and CTC Clusters Detection in Early-Stage Breast Cancer
Roberta Carbone, PhD, CSO, Tethis S.p.A
How Biospecimen Sourcing Can Impact Your R&D Programs
Vanessa Tumilasci, PhD, Commercial Director, Trans-Hit Biomarkers